Low back pain Musculoskeletal Diseases Low back pain
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Participants must be aged between 18 and 75 years 2. Participants must be affected by low back pain at least for 3 months 3. Low back pain must represent the main musculoskeletal disease 4. Participants must report a pain comprised between 2 and 6 in the last 2 weeks on a scale of 0 to 10 5. Participants must score at least 4 on the Morris Disability Questionnaire
Exclusion criteria
Exclusion criteria: Current exclusion criteria as of 13/09/2022: 1. Participants that reach the floor during the trunk flexion 2. Participants that report to have or have had spinal pathologies (e.g., cancer, infections, fractures, systemic inflammatory disorders, etc) 3. Participants that underwent surgery on the spine, chest, pelvis or lower limbs in the last year 4. Participants that have screws or other objects implanted as a consequence of a surgery 5. Participants that report musculoskeletal damages to the lower limbs or spine in the last 3 months 6. Participants that report neurological disorders (e.g., amyotrophic lateral sclerosis, stroke, Alzheimer's, etc) 7. Participants that report psychiatric disorders (e.g., schizophrenia) or taking psychotropic drugs (e.g., antipsychotics) 8. Participants with visual impairments not correctable with lenses or spectacles 9. Participants that taken muscle relaxants in the last 30 days and anti-inflammatories in the last 5 days 10. Pregnant participants or those that have given birth in the last 6 months Previous exclusion criteria: 1. Participants that reach the floor during the trunk flexion 2. Participants that report to have or have had spinal pathologies (e.g., cancer, infections, fractures, systemic inflammatory disorders, etc) 3. Participants that underwent surgery on the spine, chest, pelvis or lower limbs in the last year 4. Participants that have screws or other objects implanted as a consequence of a surgery 5. Participants that report musculoskeletal damages to the lower limbs or spine in the last 3 months 6. Participants that report neurological disorders (e.g., amyotrophic lateral sclerosis, stroke, Alzheimer's, etc) 7. Participants that report psychiatric disorders (e.g., schizophrenia) or taking psychotropic drugs (e.g., antipsychotics) 8. Participants with visual impairments not correctable with lenses or spectacles 9. Participants that taken muscle relaxants in the last 30 days and anti-inflammatories in the last 5 days 10. Participants that received therapy or a treatment for the low back pain in the last month 11. Pregnant participants or those that have given birth in the last 6 months
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The distance reached from the floor measured by a digital laser meter at every trunk flexion at baseline, after-effect and follow-up | — |
Secondary
| Measure | Time frame |
|---|---|
| The participants' a priori expectation regarding their ability to perform the main experimental task as the consequence of the sham physiotherapy treatment, measured using a five-point Likert scale. In particular, participants will express their agreement on the following displayed statement “The treatment performed will affect the mobility of my back” and they will sign to what extent they agree through a 5 point Likert-type scale (0 – “Completely disagree” / 1 “More in disagreement than in agreement” / 2 “Neither in disagreement nor in agreement” / 3 “More in agreement than in disagreement” / 4 “Completely agree”). The Likert Scale will be presented after the sham treatment in G+ and G++ groups, and before the trunk flexions. | — |
Countries
Italy